Wasserman Schultz Announces More Than $1 Million for Vital Alzheimer’s, Cancer, Addiction, Chronic Disease Treatment to FAU

Washington, March 2, 2026
“I’m beyond thrilled to announce that I was able to secure more than $1 million in federal funding for FAU to purchase Focused Ultrasound Technology for their new NeuroInnovate Center. Whether it’s from personal experience, or through a friend or family member, so many of us are touched by chronic diseases like Alzheimer’s, Parkinson’s, brain cancers, or addiction. But armed with science, we are not defenseless against them, and the focused ultrasound technology at this NeuroInnovate Center will be one of the powerful weapons in our fight,” said Wasserman Schultz. “Funding research and advances like this are always difficult, yet the threats to that work, at the federal level, are the worst they’ve ever been in my lifetime. And all my years on the House Appropriations Committee have taught me how to ensure the work of the greater good can be, and should be, done right here at home.”

Davie, FL – Today, U.S. Rep. Debbie Wasserman Schultz (FL-25) joined Florida Atlantic University (FAU) President Adam Hasner, Vice President of Research Gregg Fields, FAU researchers, and Parkinson’s Foundation of Florida Executive Director Karen Lopez to announce a $1.03 million federal investment to improve drug delivery to patients suffering from Alzheimer’s disease, brain cancers, addiction, and other chronic diseases.

To watch the full press conference, click here. 

“I’m beyond thrilled to announce that I was able to secure more than $1 million in federal funding for FAU to purchase Focused Ultrasound Technology for their new NeuroInnovate Center. Whether it’s from personal experience, or through a friend or family member, so many of us are touched by chronic diseases like Alzheimer’s, Parkinson’s, brain cancers, or addiction. But armed with science, we are not defenseless against them, and the focused ultrasound technology at this NeuroInnovate Center will be one of the powerful weapons in our fight,” said Wasserman Schultz. “Funding research and advances like this are always difficult, yet the threats to that work, at the federal level, are the worst they’ve ever been in my lifetime. And all my years on the House Appropriations Committee have taught me how to ensure the work of the greater good can be, and should be, done right here at home.”

This vital technology will advance the use of focused ultrasound treatment at FAU’s NeuroInnovate Center, and includes collaborations with Delray Medical Center and the West Palm Beach VA.

Focused ultrasound is an emerging non-invasive therapeutic technology that employs high-frequency soundwaves to precisely target areas of the body that are hard to reach or are sensitive to other surgical procedures. Focused ultrasound has shown to be effective in reducing tremors associated with Parkinson’s disease and helping temporarily open the blood-brain barrier for improved drug delivery to treat Alzheimer’s and brain cancers. Over 180 focused ultrasound clinical applications are currently in development. 

####